SCHEMBL24617679

SCHEMBL24617679

CC(C)c1ccc2cnc(-c3ccccc3)nc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.47
▸ RAB9A P51151 3/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ MAPT P10636 2/20 0.47
▸ LMNA P02545 1/20 0.47
▸ RECQL P46063 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ CYP1A2 P05177 2/20 0.44
▸ MAOA P21397 4/20 0.42
▸ MAOB P27338 4/20 0.42
▸ KMT2A Q03164 2/20 0.40
▸ NFKB1 P19838 1/20 0.39
▸ NFKB2 Q00653 1/20 0.39
▸ RELA Q04206 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ ACP1 P24666 1/20 0.38
▸ PDGFRB P09619 1/20 0.37
▸ KDR P35968 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20842894 0.88 MAOA (0.51) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL28226635 0.81 CYP1A2 (0.62) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL17689696 0.79 NPC1 (0.51) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL24604652 0.78 NPC1 (0.44) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL10199274 0.76 NPC1 (0.39) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL27991340 0.76 MAPT (0.51) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL31325776 0.76 NPC1 (0.51) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL396984 0.76 NPC1 (0.51) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL26675645 0.76 DHODH (0.48) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL31325764 0.75 NPC1 (0.59) NPC1RAB9ASMN1; SMN2MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220399506-A1 ELECTROLUMINESCENT DEVICE Beijing Summer Sprout Technology Co., Ltd. (CN) 2022-12-15 — — US disclosed
US-20220393116-A1 ELECTROLUMINESCENT DEVICE Beijing Summer Sprout Technology Co., Ltd. (CN) 2022-12-08 — — US disclosed
US-20220220084-A1 ORGANIC COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2022-07-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220393116-A1 ELECTROLUMINESCENT DEVICE L1CAM, MCOLN2, MCOLN1 NPC1 2691/4885RAB9A 570/4885SMN1; SMN2 1434/4885
US-20220220084-A1 ORGANIC COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC APPARATUS EXOC4, CYBA, SCO2 NPC1 1190/4885RAB9A 2784/4885SMN1; SMN2 2014/4885
US-20220399506-A1 ELECTROLUMINESCENT DEVICE L1CAM, LDHA, LDHB NPC1 3584/4885RAB9A 1818/4885SMN1; SMN2 3344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback